학술논문

A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
Document Type
article
Source
Nature Neuroscience. 25(9)
Subject
Biological Psychology
Biomedical and Clinical Sciences
Neurosciences
Psychology
Stem Cell Research - Embryonic - Human
Stem Cell Research - Induced Pluripotent Stem Cell
Neurodegenerative
Biotechnology
Genetics
Human Genome
Stem Cell Research
Regenerative Medicine
2.1 Biological and endogenous factors
Aetiology
Generic health relevance
Brain
Clustered Regularly Interspaced Short Palindromic Repeats
Humans
Induced Pluripotent Stem Cells
Microglia
Phagocytosis
Cognitive Sciences
Neurology & Neurosurgery
Biological psychology
Language
Abstract
Microglia are emerging as key drivers of neurological diseases. However, we lack a systematic understanding of the underlying mechanisms. Here, we present a screening platform to systematically elucidate functional consequences of genetic perturbations in human induced pluripotent stem cell-derived microglia. We developed an efficient 8-day protocol for the generation of microglia-like cells based on the inducible expression of six transcription factors. We established inducible CRISPR interference and activation in this system and conducted three screens targeting the 'druggable genome'. These screens uncovered genes controlling microglia survival, activation and phagocytosis, including neurodegeneration-associated genes. A screen with single-cell RNA sequencing as the readout revealed that these microglia adopt a spectrum of states mirroring those observed in human brains and identified regulators of these states. A disease-associated state characterized by osteopontin (SPP1) expression was selectively depleted by colony-stimulating factor-1 (CSF1R) inhibition. Thus, our platform can systematically uncover regulators of microglial states, enabling their functional characterization and therapeutic targeting.